Please login to the form below

Not currently logged in
Email:
Password:

Recipharm Italy appoints new general manager

Dr Giorgio Bruno has worked with companies such as AstraZeneca and Corden

Recipharm Giorgio BrunoCMO firm Recipharm has appointed Dr Giorgio Bruno as its new general manager of Recipharm Italia.

In this role, he will serve as CEO for all of Recipharm's Italian operating companies which employ some 257 people at three sites and have revenues of €57m.

Dr Bruno has long established senior management experience from within the pharmaceutical industry, especially in the area of manufacturing. 

He has worked in both Italian and multinational pharma companies covering a wide range of disciplines. 

In particular he has had responsibility for quality and manufacturing at such companies including Parke Davis, AstraZeneca and Corden Pharma. 

He holds a PhD in Pharmaceutical Chemistry and Technology from the University of Milan. 

Thomas Eldered, CEO of Recipharm, said: “I am very pleased to welcome Dr Bruno to the Recipharm team. We are very fortunate to have been able to attract such a competent and highly experienced manager to this important position and I look forward to him bringing his expertise to bear across our Italian operations for which he is now responsible.” 

24th April 2015

Share

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
TRIDUCIVE

Triducive are a strategic healthcare consultancy who produce communications that have practical, dynamic application that encourage behaviour change because of the...

Latest intelligence

Health literacy in the time of COVID-19
In a time when much of the media’s focus is on the ongoing COVID-19 pandemic and the differences in vaccination rates between various regions, countries, and socioeconomic groups, improving health...
Rare thoughts & outcomes - navigating pathways to better outcomes in rare
...
How to pick the perfect training program for your healthcare professionals
You know your team needs training. But not all training providers and programs are created equal. Last week, we shared the benefits of working with specialist learning and development (L&D)...